| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents at beginning of period | 1,192,230 | 1,192,230 | 1,192,230 | 889,900 |
| Net loss | -63,450 | 84,491 | 49,298 | -1,220,588 |
| Depreciation and amortization | 494,968 | 330,485 | 161,754 | 425,532 |
| Non-cash goodwill impairment charges | 181,070 | - | - | - |
| Non-cash restructuring and asset write-offs | 0 | 0 | - | 1,075,888 |
| Stock-based compensation and other | 28,048 | 17,068 | 6,966 | 24,443 |
| Equity in net income of unconsolidated investments (net of tax) | 203,184 | 142,544 | 64,286 | 696,436 |
| Dividends received from unconsolidated investments and nonmarketable securities | 89,048 | 67,765 | 60,335 | 348,358 |
| Pension and postretirement expense | 5,361 | 3,504 | 1,696 | 3,806 |
| Pension and postretirement contributions | 15,849 | 9,934 | 5,196 | 13,339 |
| Realized loss on investments in marketable securities | 0 | 0 | 0 | -33,746 |
| Unrealized (gain) loss on investments in marketable securities | 4,955 | -4,984 | -5,331 | -26,982 |
| Deferred income taxes | 10,316 | -38,907 | -5,669 | -112,777 |
| Working capital changes | -46,478 | 96,762 | 21,992 | -823,194 |
| Noncurrent liability changes and other, net | -325,931 | -318,030 | -357,146 | 17,415 |
| Net cash provided by operating activities | 893,782 | 538,180 | 545,383 | 701,394 |
| Acquisitions, net of cash acquired | - | - | - | 0 |
| Capital expenditures | 434,416 | 302,252 | 182,624 | 1,330,062 |
| Proceeds from sale of property and equipment | 25,651 | 23,751 | - | - |
| Proceeds from sale of available for sale debt securities | 288,000 | 288,000 | - | - |
| Proceeds (payments) from settlement of foreign currency forward contracts, net | -144,540 | -171,262 | - | - |
| Sales of marketable securities, net | -7,038 | -2,971 | -3,381 | -83,651 |
| Investments in equity investments and nonmarketable securities | 180 | 120 | 60 | 217 |
| Net cash provided by (used in) investing activities | 30,633 | 183,612 | -179,303 | -1,246,628 |
| Proceeds from issuance of mandatory convertible preferred stock, net of issuance costs | 0 | 0 | 0 | 2,236,750 |
| Repayments of long-term debt and credit agreements | 47,947 | 29,103 | 9,615 | 84,403 |
| Proceeds from borrowings of long-term debt and credit agreements | 38,332 | 19,488 | 0 | 84,403 |
| Other debt repayments, net | -3,694 | -2,427 | -1,195 | -629,434 |
| Dividends paid to common shareholders | 142,899 | 95,244 | 47,607 | 140,929 |
| Dividends paid to mandatory convertible preferred shareholders | 125,063 | 83,375 | 41,688 | 81,059 |
| Dividends paid to noncontrolling interests | 18,169 | 18,169 | 18,169 | 37,176 |
| Proceeds from exercise of stock options | 1,494 | 1,186 | 1,186 | 114 |
| Withholding taxes paid on stock-based compensation award distributions | 3,170 | 2,941 | 2,904 | 10,892 |
| Other | -55 | -55 | -14 | -2,758 |
| Net cash (used in) provided by financing activities | -301,171 | -210,640 | -120,006 | 1,334,616 |
| Net effect of foreign exchange on cash and cash equivalents | 116,284 | 103,447 | 80,207 | -14,763 |
| Increase in cash and cash equivalents | 739,528 | 614,599 | 326,281 | 774,619 |
| Cash and cash equivalents at end of period | 1,931,758 | 1,806,829 | 1,518,511 | 1,664,519 |
ALBEMARLE CORP (ALB)
ALBEMARLE CORP (ALB)